At the conclusion of this meeting, attendees should be able to:
* Identify the common and uncommon patient preparation pitfalls which result in FDG PET/CT study rescheduling.
* Review contraindications in pharmacologic and exercise stress testing
* Discuss the research residents and basic scientist trainees are conducting at their respective institutions Detail the clinical trial support for the use of radium- 223 in castrate-resistant prostate cancer
* Describe exposure levels from Nuclear Medicine procedures and compare those to radiologic studies and other sources of radiation exposure
* Discuss the new billing codes and how to implement them
* Describe informatics methods for measuring, monitoring and helping to improve quality of patient care